Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Kyriacos Mitrophanous, Jean Marc Gurruchaga et al.|The Lancet|2014Cited by 436
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s diseaseRoger A. Barker, Olle Lindvall, Hjálmar Bjartmarz et al.|Nature Biotechnology|2025Cited by 15